Can I bring iii Partners in before I've signed the LOI — during diligence?

Yes, and that is often the best time. A preliminary read of the target's operational cost structure can sharpen your thesis before you commit, and a diagnostic commissioned during diligence gives you documentation that goes straight into the data room when you are raising equity.

How do I present this to my equity co-investors without it sounding like a vendor relationship?

The framing is outcome alignment, not a vendor contract. iii Partners is paid for what the business earns — not for software delivered. The diagnostic produces a measurable projection that your co-investors can diligence independently. That accountability structure is the thing worth leading with in the raise conversation.

What kinds of businesses actually fit — and what gets you to a quick no?

The right fit is a labour-heavy business above $500k EBITDA where a large share of cost is repetitive human process — field services, multi-site staffing, logistics, distribution, back-office-heavy services. A quick no: businesses where cost is primarily materials or capital rather than labour, anything already running lean and digitised, owner-dependent shops where the owner is the product, and anything below $500k EBITDA.

What happens if the diagnostic doesn't show the margin lift we expected?

Then you have a documented answer before you raise capital — which is far better than discovering it after close. The diagnostic is designed to be honest, not to confirm a thesis. If the lift isn't there, we tell you. That is what risk-reversed means in practice.

iii Partners for Independent Sponsors: Win the Deal, Then Prove the Value-Creation Story

You found the company. You signed the LOI. Now you have sixty days to convince a capital partner that your thesis isn't just a slide — that the margin lift is real, that day-one operational control is real, and that you can beat a funded buyer who already has a platform and a back-office. That's the problem iii Partners was built to solve.

The Pressure Every Independent Sponsor Knows

You are competing against buyers who show up with a committed fund, a full operating team, and a portfolio of proof points. You have a deal, a thesis, and yourself. The question every LP or equity co-investor asks — out loud or not — is: *what happens on day one when you own this thing?*

For a labour-heavy business — a field-services company, a multi-site staffing operation, a distribution or logistics business running on spreadsheets and tribal knowledge — "day one" is where value-creation plans quietly die. The operator is still calling the same people. The same manual processes are eating margin. The slide that said "operational improvement" stays a slide.

The gap between your value-creation narrative and a capital partner's confidence in it is the gap iii Partners closes — before the deal closes, and verifiably.

What "Operating Machine on Day One" Actually Means

iii Partners built five integrated operational pillars to run its own companies. Not a toolkit. Not a software subscription. A governed, AI-native operating stack that instruments a business, identifies where large shares of cost are repetitive human process, and changes the margin structure — measurably.

For an independent sponsor, that machine becomes part of the equity story you are already selling:

Instrumentation first. We map where labour hours and process cost actually live in the target — not a consultant's estimate, a real read of the business.
AI-native stack against repetitive cost. The pillars run against the specific workflows that are eating margin: scheduling, dispatch, billing cycles, exception handling, whatever the business's version of repetitive human process looks like.
Governed by a published standard. This isn't a bespoke build that disappears when the engagement ends. It is a governed standard we own and operate — which means your capital partner can diligence it.
Outcome accountability. We are paid for what the business earns, not for the software delivered. That alignment is something you can put in front of an equity co-investor.

This is the operating plan that exists *before* you ask for capital — not the one you promise to figure out after.

How It Fits the Independent Sponsor's Raise

The sequence that works:

Step one — twenty minutes, partner to partner. Bring us the target or a deal you are actively working. We walk one labour-heavy business and show where the margin lift is structurally available. No demo, no capability pitch — a conversation about the specific business and what it could earn.

Step two — risk-reversed diagnostic. Before any larger commitment, we run a short diagnostic scoped to the deal. It produces a documented read of the operational inefficiency and a credible projection of the margin improvement. That document goes into your data room. It is the difference between a value-creation slide and a value-creation plan.

Step three — the machine goes in on close. When you own the business, the operating stack is already designed and ready. Day one is not a promise — it is a scheduled deployment against a documented plan.

For the capital partner evaluating your deal, the question shifts from *"do we trust this sponsor's operational claims?"* to *"is this diagnostic credible?"* That is a much easier conversation.

Why This Beats Paying More

Funded buyers win on certainty — they can close faster and absorb integration risk because they have the infrastructure. You win on a different axis: a tighter, more credible value-creation story backed by a pre-committed operating plan that a funded buyer's platform doesn't automatically provide.

The businesses iii Partners is built for — labour-heavy, low-margin, unglamorous, running on repetitive human process — are exactly the businesses where a funded buyer's existing platform is often a poor fit. Their portfolio companies run different processes. Their operating partners are stretched. The integration is slower than the slide implies.

Your edge is specificity. A diagnostic that maps *this* business's cost structure, a machine designed for *this* type of operation, and an outcome commitment that a capital partner can hold you — and us — accountable to.

That is a competitive position that doesn't require you to pay a dollar more.

Getting Started

Contact us to ask for twenty minutes with Scott — partner to partner, no demo, no sales process. Bring a target you are working on, or a deal type you are actively sourcing. We will tell you honestly whether the business fits, where we see the margin, and what a diagnostic would look like. Contact for current pricing on diagnostic and engagement structures.

FAQ

Can I bring iii Partners in before I've signed the LOI — during diligence?: Yes, and that is often the best time. A preliminary read of the target's operational cost structure can sharpen your thesis before you commit, and a diagnostic commissioned during diligence gives you documentation that goes straight into the data room when you are raising equity.
How do I present this to my equity co-investors without it sounding like a vendor relationship?: The framing is outcome alignment, not a vendor contract. iii Partners is paid for what the business earns — not for software delivered. The diagnostic produces a measurable projection that your co-investors can diligence independently. That accountability structure is the thing worth leading with in the raise conversation.
What kinds of businesses actually fit — and what gets you to a quick no?: The right fit is a labour-heavy business above $500k EBITDA where a large share of cost is repetitive human process — field services, multi-site staffing, logistics, distribution, back-office-heavy services. A quick no: businesses where cost is primarily materials or capital rather than labour, anything already running lean and digitised, owner-dependent shops where the owner is the product, and anything below $500k EBITDA.
What happens if the diagnostic doesn't show the margin lift we expected?: Then you have a documented answer before you raise capital — which is far better than discovering it after close. The diagnostic is designed to be honest, not to confirm a thesis. If the lift isn't there, we tell you. That is what risk-reversed means in practice.